|
SPRY Ars Pharmaceuticals Inc 1671858 |
| Balance Sheet |
|
Current Assets
|
208,789,000 |
|
Assets
|
217,601,000 |
|
Current Liabilities
|
16,623,000 |
|
Liabilities
|
16,623,000 |
|
Equity
|
200,978,000 |
|
Shares Out
|
99,297,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-28,456,000 |
|
Investing Cash Flow
|
-4,341,000 |
| Market Analysis |
Market Cap
|
834,097,282 |
|
Price
|
8.40 |
|
BVPS
|
2.07 |
|
PB
|
5.66 |
|
EPS
|
-1.74 |
|
PS
|
150.01 |
|
FCF
|
-32,797,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SPRY documents filed with the SEC.
SPRY Filings
Clear
